Ymmunobio
Ymmunobio is a preclinical-stage oncology platform founded in 2021.
1
Funding Rounds
$1.4m
Money raised
Overview
Ymmunobio is a preclinical-stage oncology platform founded in 2021.
- Website:
- Headquarters: Basel
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Ymmunobio has raised a total of $1.4m in funding over 1 rounds.
Key Insights:
- Ymmunobio November 2023 Seed Funding Round: $1.4m
Ymmunobio November 2023 Seed Funding Round
$1.4m